Rare Disease Clinical Trials Go Uncompleted and Unpublished

December 10, 2019

Rare Disease Clinical Trials Go Uncompleted and Unpublished

A new study published in PLOS Medicine investigating 659 clinical trials for rare diseases found that over half of the trials either were discontinued or the results went unpublished four years after completion. For both the incomplete and the unpublished studies, the primary reason was difficulties enrolling sufficient numbers of patients. Yourway is constantly exploring ways to facilitate trials for rare diseases, including direct-to-patient trials services and other new trials models.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Schedule a Meeting

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Schedule a Meeting

Media

Articles

Global Reach in Clinical Trials: Beyond Presence to True Execution

Open chat

Hello! How can I help you?